IBG-PHARMA Platform
IBG-PHARMA Platform
IBG-PHARMA Platform
IBG-PHARMA Platform
Services and Research Areas
Publications
Projects and Patents
Staff
Researchers / Senior Researchers

Publications

Kalyoncu S, Sayili D, Kuyucu AZ, Soyturk H, Gullu S, Ersayan B, Tarman IO, Avci ME, Mert O, Haskok U, Tekin E, Akinturk H, Orkut R, Demirtas A, Tilmensagir I, Ulker C, Gungor B, Inan M. Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris.. Microbial biotechnology. 2025 January ; 18 (1): e70077. doi:10.1111/1751-7915.70077.

Kuyucu, A. Z., Sayili, D., Orkut, R., Mert, O., Tarman, İ. O., Lulaci, B., Sencer, A. M., Pekmezci, A. K., Avci, M. E., Kalyoncu, S., & Inan, M. (2024). Cell line development and bioreactor process optimization for an atezolizumab biosimilar. Biotechnology and applied biochemistry, 10.1002/bab.2704. Advance online publication. https://doi.org/10.1002/bab.2704

Kalyoncu S, Yilmaz S, Kuyucu AZ, Sayili D, Mert O, Soyturk H, Gullu S, Akinturk H, Citak E, Arslan M, Taskinarda MG, Tarman IO, Altun GY, Ozer C, Orkut R, Demirtas A, Tilmensagir I, Keles U, Ulker C, Aralan G, Mercan Y, Ozkan M, Caglar HO, Arik G, Ucar MC, Yildirim M, Yildirim TC, Karadag D, Bal E, Erdogan A, Senturk S, Uzar S, Enul H, Adiay C, Sarac F, Ekiz AT, Abaci I, Aksoy O, Polat HU, Tekin S, Dimitrov S, Ozkul A, Wingender G, Gursel I, Ozturk M, Inan M. Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris.. Scientific reports. 2023 March ; 13 (1) : 5224. doi:10.1038/s41598-023-32021-9.

Erden-Karaoğlan F, Karaoğlan M, Yılmaz G, Yılmaz S, İnan M. Deletion analysis of Pichia pastoris alcohol dehydrogenase 2 (ADH2) promoter and development of synthetic promoters.. Biotechnology journal. 2022 February; 17 (2) : e2100332. doi:10.1002/biot.202100332.

Karaoğlan M, Erden-Karaoğlan F, Yılmaz S, İnan M. Identification of major ADH genes in ethanol metabolism of Pichia pastoris.. Yeast. 2020 February; 37 (2) : 227-236. doi:10.1002/yea.3443.